The antibody’s specificity is critical for reliable results:
Cross-reactivity: No reported cross-reactivity with unmodified Tyr88 or other histone H4 modifications (e.g., acetylated or methylated residues) based on peptide array screening .
Validation Data:
While the functional role of Y88 hydroxylation in histone H4 remains under investigation, studies on analogous histone PTMs provide insights:
Epigenetic Regulation: Histone H4 modifications (e.g., acetylation, phosphorylation) influence chromatin structure and gene expression . Hydroxylation may similarly modulate DNA accessibility or protein interactions.
Comparative Studies: Antibodies against phosphorylated Tyr88 (pY88-H4) have been used to map androgen receptor (AR) gene regulation in prostate cancer, highlighting the importance of tyrosine modifications in disease pathways .
Specificity Challenges: Antibodies targeting PTMs require rigorous validation due to potential cross-reactivity with structurally similar epitopes . The Histone Antibody Specificity Database (source 8) recommends verifying antibodies using peptide microarrays.
Application Guidelines:
Further research is needed to:
Map genome-wide occupancy of Y88-hydroxylated H4 using chromatin immunoprecipitation (ChIP-seq).
Investigate crosstalk between hydroxylation and other histone modifications (e.g., acetylation or methylation).
The Hydroxyl-HIST1H4A (Y88) Antibody is a research-grade monoclonal antibody specifically designed to recognize and bind to the hydroxylated tyrosine 88 residue on histone H4. This antibody typically recognizes a specific epitope containing the hydroxylated Y88 residue within its surrounding amino acid sequence. The specificity of this antibody is critical for distinguishing between hydroxylated and non-hydroxylated forms of Y88, allowing researchers to investigate this particular post-translational modification in various experimental contexts.
Unlike antibodies targeting acetylated residues such as the Anti-Acetyl-Histone H4 (Lys5) antibody described in the search results , the Hydroxyl-HIST1H4A (Y88) Antibody targets a different type of modification (hydroxylation) and a distinct residue (Y88) on the histone H4 protein. This specificity makes it a valuable tool for investigating the unique biological roles of tyrosine hydroxylation in chromatin regulation.
Tyrosine hydroxylation at Y88 of histone H4 represents a distinct post-translational modification compared to more extensively studied modifications such as acetylation, methylation, or phosphorylation. Unlike acetylation at lysine residues (such as K5 on histone H4 ), which neutralizes the positive charge and generally promotes open chromatin structures, tyrosine hydroxylation introduces a polar hydroxyl group that can alter protein-protein interactions and DNA binding properties through hydrogen bonding capabilities.
The functional implications of Y88 hydroxylation differ from those of other modifications in several important ways:
| Modification Type | Common Residues | Functional Impact | Detection Methods |
|---|---|---|---|
| Acetylation | Lysine (K) | Neutralizes positive charge; promotes open chromatin | Western blot, ChIP, mass spectrometry |
| Methylation | Lysine (K), Arginine (R) | Variable effects depending on position and degree | Western blot, ChIP, mass spectrometry |
| Phosphorylation | Serine (S), Threonine (T), Tyrosine (Y) | Adds negative charge; alters protein interactions | Western blot, ChIP, mass spectrometry |
| Hydroxylation | Tyrosine (Y) | Alters hydrogen bonding; affects protein interactions | Western blot, ChIP-seq, mass spectrometry |
Unlike well-characterized modifications such as H4K5 acetylation, the full biological significance of Y88 hydroxylation remains an active area of investigation, requiring highly specific antibodies for accurate detection and characterization.
The Hydroxyl-HIST1H4A (Y88) Antibody can be employed across multiple experimental techniques to investigate tyrosine hydroxylation in various research contexts. Based on the applications of similar histone modification antibodies , the following techniques are particularly suitable:
Western Blotting (WB): For quantitative analysis of global Y88 hydroxylation levels in cell or tissue lysates. Typical dilutions would range from 1:500 to 1:2000, depending on antibody concentration and specificity.
Immunocytochemistry (ICC)/Immunofluorescence (IF): For visualizing the nuclear localization and distribution patterns of hydroxylated H4Y88 in fixed cells. This approach allows for correlation with other nuclear markers or histone modifications.
Chromatin Immunoprecipitation (ChIP): For identifying genomic regions associated with hydroxylated H4Y88, providing insights into its potential role in gene regulation.
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of hydroxylated H4Y88 levels in purified histone preparations or nuclear extracts.
Luminex-based multiplex assays: For simultaneous detection of multiple histone modifications, including H4Y88 hydroxylation, allowing for correlation studies between different epigenetic marks.
Each application requires specific optimization steps to ensure sensitivity and specificity, particularly given the relatively low abundance of tyrosine hydroxylation compared to other histone modifications.
Western blot protocols for detecting hydroxylated H4Y88 require specific optimization steps to ensure sensitivity and specificity. Based on standard practices for histone modification antibodies:
Sample preparation:
Use histone extraction protocols that preserve hydroxylation modifications
Consider using histone deacetylase inhibitors (like sodium butyrate) and protease inhibitors in lysis buffers
Include antioxidants (e.g., sodium ascorbate) to prevent oxidation of hydroxyl groups
Gel electrophoresis:
Use 15-18% SDS-PAGE gels to achieve good separation of the low molecular weight histone proteins
Load appropriate amount of histones (typically 5-15 μg of acid-extracted histones)
Transfer and blocking:
Use PVDF membranes for optimal protein binding
Consider wet transfer at low voltage (30V) overnight at 4°C for efficient transfer of small proteins
Block with 5% BSA in TBST rather than milk (milk contains phosphoproteins that may interfere)
Antibody incubation:
Use optimized antibody dilution (typically 1:1000 for primary antibody)
Incubate overnight at 4°C with gentle rocking
Include phosphatase inhibitors in antibody dilution buffers
Detection:
Use high-sensitivity ECL substrates due to potentially low abundance of the hydroxylation mark
Consider longer exposure times than typically used for more abundant modifications
These optimization steps should be adjusted based on the specific properties of the Hydroxyl-HIST1H4A (Y88) Antibody and the experimental system being studied.
Validating antibody specificity is crucial for ensuring reliable experimental results, particularly for antibodies targeting post-translational modifications. For the Hydroxyl-HIST1H4A (Y88) Antibody, several approaches can be used:
Peptide competition assays: Compare antibody binding with and without pre-incubation with:
Hydroxylated Y88 peptide (should block binding)
Unmodified Y88 peptide (should not block binding)
Peptides with other modifications at Y88 (should not block binding)
Knockout/knockdown validation:
Test antibody reactivity in cells where enzymes responsible for Y88 hydroxylation have been depleted
Use CRISPR/Cas9 to generate Y88F mutants (prevents hydroxylation) and confirm loss of antibody reactivity
Mass spectrometry correlation:
Perform ChIP-MS or immunoprecipitation followed by mass spectrometry to confirm the antibody is capturing the hydroxylated form of Y88
Compare antibody-based quantification with MS-based quantification of hydroxylation levels
Cross-reactivity testing:
Proper validation experiments should be conducted and documented before using the antibody in critical research applications.
Including appropriate controls is essential for interpreting results obtained with the Hydroxyl-HIST1H4A (Y88) Antibody. The following controls should be considered:
Technical controls:
No primary antibody control: To assess background from secondary antibody
Isotype control: Using an irrelevant antibody of the same isotype
Blocking peptide control: Pre-incubating the antibody with excess hydroxylated Y88 peptide
Biological controls:
Treatment controls: Cells treated with inhibitors of enzymes involved in tyrosine hydroxylation
Positive controls: Samples known to have high levels of Y88 hydroxylation
Negative controls: Y88F mutant histones or cells where hydroxylation is absent
Validation controls:
Secondary antibody-only controls for immunofluorescence
Input controls for ChIP experiments
Loading controls for Western blots (total H4 or another stable protein)
Cross-technique validation:
Confirm findings using alternative detection methods (e.g., mass spectrometry)
Use multiple antibody clones targeting the same modification if available
These controls help distinguish specific signal from background and validate the biological significance of the observed patterns of Y88 hydroxylation.
ChIP-seq using the Hydroxyl-HIST1H4A (Y88) Antibody can provide valuable insights into the genomic distribution of this modification and its potential role in gene regulation. Based on established protocols for histone modification ChIP-seq:
Chromatin preparation:
Optimize fixation conditions (typically 1% formaldehyde for 10 minutes)
Consider using dual crosslinking with additional protein-protein crosslinkers
Ensure appropriate sonication to generate 200-500 bp fragments
Include antioxidants in buffers to preserve hydroxyl modifications
Immunoprecipitation:
Determine optimal antibody amount through titration experiments (typically 2-5 μg per ChIP)
Use longer incubation times (overnight at 4°C)
Include specific blocking agents to reduce background
Perform stringent washes to remove non-specific binding
Library preparation and sequencing:
Use library preparation methods suitable for limited material
Consider using spike-in controls for quantitative comparisons
Aim for deeper sequencing (>30 million reads) due to potentially sparse genomic distribution
Data analysis considerations:
Use appropriate peak calling algorithms (e.g., MACS2 with parameters optimized for histone modifications)
Compare with distributions of other histone marks
Correlate with gene expression data to infer functional significance
Analyze motif enrichment to identify potential sequence preferences
This approach can reveal the genomic regions where Y88 hydroxylation occurs and provide insights into its potential regulatory functions.
Understanding the relationship between Y88 hydroxylation and other histone modifications is important for deciphering the "histone code." While specific research on Y88 hydroxylation interactions is emerging, general principles from histone modification studies suggest:
Co-occurrence patterns:
Certain modifications may positively correlate with Y88 hydroxylation (synergistic relationship)
Other modifications may negatively correlate (antagonistic relationship)
Sequential modifications may occur where one modification facilitates or inhibits Y88 hydroxylation
Functional interactions:
Y88 hydroxylation may influence the binding of reader proteins for other modifications
The hydroxyl group could form hydrogen bonds that alter chromatin structure
Hydroxylation could impact the activity of enzymes that add or remove other modifications
Integrated analysis approaches:
Mass spectrometry to identify co-occurring modifications on the same histone tail
Sequential ChIP (Re-ChIP) to identify genomic regions with multiple modifications
Correlative ChIP-seq analysis to identify patterns of co-occurrence genome-wide
| Potential Interaction | Possible Mechanism | Experimental Approach |
|---|---|---|
| H4K5 acetylation and Y88 hydroxylation | Structural changes in histone tail affecting accessibility | Sequential ChIP, mass spectrometry of modified histones |
| H4R3 methylation and Y88 hydroxylation | Potential reader protein competition | In vitro binding assays, structural studies |
| H3K9 methylation and H4Y88 hydroxylation | Potential cross-talk in heterochromatin formation | Correlative ChIP-seq, fluorescence microscopy |
Understanding these relationships requires integrative approaches combining multiple techniques and computational analyses.
Working with antibodies targeting histone modifications presents several challenges. For the Hydroxyl-HIST1H4A (Y88) Antibody, researchers may encounter:
Low signal intensity:
Increase antibody concentration or incubation time
Use signal amplification methods (e.g., TSA for immunofluorescence)
Optimize extraction methods to preserve hydroxylation
Include antioxidants in all buffers to prevent loss of hydroxyl groups
High background or non-specific binding:
Optimize blocking conditions (try different blocking agents: BSA, normal serum, commercial blockers)
Increase washing stringency (higher salt concentration, longer washes)
Pre-adsorb antibody with non-specific proteins
Use monovalent Fab fragments instead of complete IgG antibodies
Batch-to-batch variability:
Validate each new antibody lot against previous lots
Maintain reference samples for comparison
Consider producing large batches of antibody for long-term projects
Cross-reactivity issues:
Conduct thorough validation using peptide arrays
Use knockout/mutation controls
Consider alternative antibody clones or custom antibody development
Technical variability in ChIP experiments:
Standardize chromatin preparation methods
Include spike-in controls for normalization
Use automated systems for consistent sample handling
Addressing these challenges requires systematic optimization and careful experimental design.
Sample preparation significantly impacts the detection of histone modifications, particularly for potentially labile modifications like hydroxylation:
Cell/tissue lysis considerations:
Use denaturing conditions promptly to inactivate enzymes that might remove modifications
Include appropriate enzyme inhibitors (HDACs, phosphatases, proteases)
Add antioxidants to prevent oxidative damage to hydroxyl groups
Minimize exposure to freeze-thaw cycles
Histone extraction methods:
Acid extraction (0.2N HCl or 0.4N H2SO4) is generally suitable for preserving most modifications
Alternative: high-salt extraction with 420mM NaCl can be gentler for certain modifications
Avoid harsh detergents that might affect protein-protein interactions
Fixation for immunocytochemistry:
Optimize paraformaldehyde concentration and fixation time (typically 2-4% for 10-20 minutes)
Consider epitope retrieval methods if necessary (heat-induced or enzymatic)
Test alternative fixatives that may better preserve hydroxyl groups (e.g., Methanol/Acetone)
Storage considerations:
Store samples at -80°C with protease inhibitors and antioxidants
Minimize repeat freeze-thaw cycles
Consider preparing aliquots to avoid repeated handling of stock samples
Protein degradation prevention:
Add protease inhibitors freshly to all buffers
Work at 4°C whenever possible
Process samples quickly to minimize degradation time
Careful optimization of these parameters is essential for reliable and reproducible detection of hydroxylated H4Y88.
Emerging research suggests potential roles for histone tyrosine hydroxylation in various disease processes, though this area remains actively investigated:
Cancer biology:
Preliminary evidence suggests altered patterns of histone hydroxylation in certain cancer types
Changes in hydroxylation may affect gene expression programs involved in cell proliferation and metastasis
Potential therapeutic target through modulation of the enzymes controlling hydroxylation
Inflammatory disorders:
Possible links between oxidative stress, hydroxylation signaling, and inflammatory gene expression
Altered hydroxylation patterns may contribute to dysregulated immune responses
Understanding these connections may reveal new therapeutic approaches
Neurological disorders:
Brain tissue exhibits unique patterns of histone modifications
Y88 hydroxylation may play roles in neuronal gene expression and plasticity
Dysregulation could contribute to neurodegenerative or neurodevelopmental disorders
Metabolic diseases:
Connections between cellular metabolism, oxygen sensing, and histone hydroxylation
Potential role in metabolic adaptation and stress responses
May contribute to pathophysiology of metabolic syndrome and related disorders
Investigating these disease connections requires carefully validated antibodies and integrated multi-omics approaches to establish causative relationships rather than correlative observations.
Single-cell approaches represent the cutting edge of epigenetic research, allowing for analysis of cellular heterogeneity in hydroxylation patterns:
Single-cell approaches:
Emerging single-cell ChIP-seq protocols can be adapted for hydroxylated H4Y88
CUT&Tag and CUT&RUN methods offer higher sensitivity for limited material
Mass cytometry (CyTOF) with metal-conjugated antibodies against hydroxylated H4Y88
Single-cell ATAC-seq combined with antibody-based enrichment for hydroxylated regions
Spatial technologies:
Imaging-based approaches like Imaging Mass Cytometry (IMC) to visualize hydroxylation in tissue context
Multiplexed immunofluorescence to correlate Y88 hydroxylation with other cellular markers
In situ sequencing approaches combined with antibody detection
Technical considerations for single-cell methods:
Antibody specificity becomes even more critical at single-cell resolution
Optimization of fixation and permeabilization for antibody accessibility
Development of spike-in controls and normalization methods for quantitative comparisons
Computational approaches for integrating hydroxylation data with other single-cell modalities
These advanced methods promise to reveal the heterogeneity and dynamics of Y88 hydroxylation at unprecedented resolution, potentially uncovering new biological insights that are masked in bulk population analyses.